Accessibility Menu
 
Neuberger Berman Income Funds - Neuberger High Yield Strategies Fund logo

Neuberger Berman Income Funds - Neuberger High Yield Strategies Fund

(NYSEMKT) NHS

Current Price$6.54
Market Cap$204.99M
Since IPO (2003)+307%
5 Year-1%
1 Year+12%
1 Month-11%

Neuberger Berman Income Funds - Neuberger High Yield Strategies Fund Financials at a Glance

Market Cap

$204.99M

Revenue (TTM)

$49.52M

Net Income (TTM)

$58.16M

EPS (TTM)

$0.66

P/E Ratio

9.89

Dividend

$1.18

Beta (Volatility)

0.45 (Low)

Price

$6.54

Volume

396,628.053

Open

$6.64

Previous Close

$6.55

Daily Range

$6.52 - $6.64

52-Week Range

$6.26 - $7.80

NHS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Neuberger Berman Income Funds - Neuberger High Yield Strategies Fund

Industry

Capital Markets

CEO

Joe Amato

Headquarters

New York City, NY 10104, US

NHS Financials

Key Financial Metrics (TTM)

Gross Margin

50%

Operating Margin

95%

Net Income Margin

76%

Return on Equity

9%

Return on Capital

8%

Return on Assets

6%

Earnings Yield

10.11%

Dividend Yield

0.18%

Payout Ratio

1.63%

Stock Overview

Market Cap

$204.99M

Shares Outstanding

31.39M

Volume

396.63K

Short Interest

0.00%

Avg. Volume

268.60K

Financials (TTM)

Gross Profit

$24.47M

Operating Income

$25.42M

EBITDA

$25.42M

Operating Cash Flow

$13.64M

Capital Expenditure

$4.00

Free Cash Flow

$13.64M

Cash & ST Invst.

$11.60M

Total Debt

$101.18M

Neuberger Berman Income Funds - Neuberger High Yield Strategies Fund Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$14.54M

+23.3%

Gross Profit

$13.37M

+13.4%

Gross Margin

91.95%

N/A

Market Cap

$204.99M

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

$16.91M

+460.6%

EBITDA

$19.73M

N/A

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$89.58M

-35.7%

Accounts Receivable

$5.59M

-29.4%

Inventory

$0.00

N/A

Long Term Debt

$100.98M

-4.7%

Short Term Debt

$201.38K

-66.6%

Return on Assets

5.95%

N/A

Return on Invested Capital

7.60%

N/A

Free Cash Flow

$11.28M

+768.9%

Operating Cash Flow

$11.28M

+768.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SILVXSGI U.S. Large Cap Equity Fund Class I
$18.14+1.85%
SDVSXSit Dividend Growth Fund Class S
$16.87+2.24%
MVTBlackRock MuniVest Fund II, Inc.
$11.00+0.19%
RYVFXRoyce Small-Cap Value Fund - Service Class
$10.57+2.42%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$58.95+0.11%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.29-0.02%
NOKNokia
$9.44+0.07%
TQQQProShares Trust - ProShares UltraPro Qqq
$48.00+0.09%

Questions About NHS

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.